Kepro: Building a market leader in technology-enabled services for priority populations 

Kepro is a leading provider of technology-enabled services for priority populations to help them remain in the home or community of their choice. Kepro partners with government and private healthcare players to maximise healthcare quality, improve accuracy and increase efficiency.


The Apax Funds acquired Kepro to help the business grow into a market leader in a fragmented, growing category. Its attractive and efficient business model provided good revenue visibility and strong margins. With a broad range of capabilities, Kepro was positioned to grow through both its long-standing, existing customer base and new business wins.


The Apax Funds completed the acquisition of Kepro from Consonance Capital in May 2017, following an extensive due diligence process.


  • Strategic repositioning: The Apax Funds and management re-directed Kepro’s strategic focus towards prioritising higher value clinical solutions and contracts that could benefit from its in-house technology capabilities
  • Organic Growth Acceleration: With the support of Apax’s Operational Excellence Practice, invested heavily in sales and marketing, which accelerated new contract wins
  • Talent: Revamped the management team and board of directors with experienced managers / industry experts. Key new hires at the CEO, CFO, Chief Growth Officer, Chief Legal & Compliance Officer, Chief Product Officer, and Chief Human Resources Officer levels.
  • M&A: Executed three strategic acquisitions that strengthened the business by adding differentiated capabilities and expanding the Company’s customer footprint.  These acquisitions were completed at attractive valuations and sourced through the Apax network.


The Apax Funds sold their entire stake in Kepro in November 2022 to CNSI, a provider of healthcare technology products and solutions and a portfolio company of The Carlyle Group.

Investment year




Deal status